Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05903950

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05903950
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Qatar (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05903950. Randomized; triple masking; primary purpose prevention. Start 2024-11-03 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Acronym
APCIQ-BP
Condition
Hypertension, Systolic
Condition
Typ 2 Diabetes
Intervention (Device)
Air cleaners with HEPA filter
Intervention (Device)
Air cleaners without HEPA filter
Lead sponsor
Weill Cornell Medical College in Qatar (class: other)
Collaborator
Hamad Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct05903950
Content hash
a49591221dccabc899c1fda325222a3d992f1cef4d4e32d0dd706bb90f3a9f83